Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Article

  • Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers
    Masaaki Komatsu, Keiko Hiyama, Keiji Tanimoto, Mayu Yunokawa, Keiko Otani, Megu Ohtaki, Eiso Hiyama, Junzo Kigawa, Michitaka Ohwada, Mitsuaki Suzuki, Nobutaka Nagai, Yoshiki Kudo, Masahiko Nishiyama
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 767-775; DOI: 10.1158/1535-7163.MCT-05-0408
  • Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non–small cell lung cancer cells (H1299)
    Elvira Crescenzi, Angela Chiaviello, Gianfranco Canti, Elena Reddi, Bianca Maria Veneziani, Giuseppe Palumbo
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 776-785; DOI: 10.1158/1535-7163.MCT-05-0425
  • Identification of a small topoisomerase I–binding peptide that has synergistic antitumor activity with 9-aminocamptothecin
    Christopher D. Pond, Kathryn M. Marshall, Louis R. Barrows
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 739-745; DOI: 10.1158/1535-7163.MCT-05-0377
  • Sulindac independently modulates extracellular signal–regulated kinase 1/2 and cyclic GMP–dependent protein kinase signaling pathways
    Pamela L. Rice, Stevany L. Peters, K. Scott Beard, Dennis J. Ahnen
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 746-754; DOI: 10.1158/1535-7163.MCT-05-0210
  • Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
    Svetlana Komarova, Yosuke Kawakami, Mariam A. Stoff-Khalili, David T. Curiel, Larisa Pereboeva
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 755-766; DOI: 10.1158/1535-7163.MCT-05-0334
  • Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells
    Ruoping Tang, Anne-Marie Faussat, Patricia Majdak, Christophe Marzac, Sabine Dubrulle, Zora Marjanovic, Ollivier Legrand, Jean-Pierre Marie
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 723-731; DOI: 10.1158/1535-7163.MCT-05-0164
  • Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine
    Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, Yasunori Yoshimoto, Christi Augustine, Zeinab Abdel-Wahab, Tsung-Yen Cheng, Omar I. Abdel-Wahab, Scott K. Pruitt, Henry S. Friedman, Douglas S. Tyler
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 732-738; DOI: 10.1158/1535-7163.MCT-05-0098
  • Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells
    Lincoln A. Edwards, Maite Verreault, Brian Thiessen, Wieslawa H. Dragowska, Yanping Hu, Juliana H.F. Yeung, Shoukat Dedhar, Marcel B. Bally
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 645-654; DOI: 10.1158/1535-7163.MCT-05-0099
  • The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor
    Kate F. Byth, Catherine Geh, Cheryl L. Forder, Sandra E. Oakes, Andrew P. Thomas
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 655-664; DOI: 10.1158/1535-7163.MCT-05-0205
  • Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
    Jordi Codony-Servat, Maria A. Tapia, Marta Bosch, Cristina Oliva, Josep Domingo-Domenech, Begoña Mellado, Mark Rolfe, Jeffrey S. Ross, Pere Gascon, Ana Rovira, Joan Albanell
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 665-675; DOI: 10.1158/1535-7163.MCT-05-0147

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 69
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement